Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference14 articles.
1. Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers;T Dörner;Pharmacol Ther,2010
2. Roles of B cells in rheumatoid arthritis;GJ Silverman;Arthritis Res Ther,2003
3. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;SB Cohen;Arthritis Rheum,2006
4. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;JC Edwards;N Engl J Med,2004
5. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial;P Emery;Arthritis Rheum,2006
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial;The Lancet Neurology;2024-06
2. B-cell depletion in autoimmune diseases;Annals of the Rheumatic Diseases;2024-05-22
3. Ocrelizumab Kullanan Multipl Skleroz Hastalarında Hepatit B Virüsü Serolojisi;Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi;2023-11-20
4. Rituximab in der Immuntherapie der Multiplen Sklerose;NeuroTransmitter;2022-08
5. Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients;Frontiers in Immunology;2022-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3